Zhao WL - Search Results

1

Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma.

Liu YY, Leboeuf C, Shi JY, Li JM, Wang L, Shen Y, Garcia JF, Shen ZX, Chen Z, Janin A, Chen SJ, Zhao WL. Liu YY, et al. Among authors: zhao wl. Blood. 2007 Jul 1;110(1):339-44. doi: 10.1182/blood-2006-09-049189. Epub 2007 Mar 22. Blood. 2007. PMID: 17379744 Free article.

2

The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution.

Zhao WL, Xu L, Wu W, Yan H, Tang W, Hu J, Chen Y, Li JM, Zeng XY, Xiong SM, Shen ZX, Chen Z, Wang ZY, Chen SJ. Zhao WL, et al. Hematol J. 2002;3(3):137-44. doi: 10.1038/sj.thj.6200173. Hematol J. 2002. PMID: 12111649

3

Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma.

Zhao WL, Daneshpouy ME, Mounier N, Brière J, Leboeuf C, Plassa LF, Turpin E, Cayuela JM, Ameisen JC, Gisselbrecht C, Janin A. Zhao WL, et al. Blood. 2004 Jan 15;103(2):695-7. doi: 10.1182/blood-2003-06-1901. Epub 2003 Sep 11. Blood. 2004. PMID: 12969962 Free article.

4

Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression.

Zhao WL, Mourah S, Mounier N, Leboeuf C, Daneshpouy ME, Legrès L, Meignin V, Oksenhendler E, Maignin CL, Calvo F, Brière J, Gisselbrecht C, Janin A. Zhao WL, et al. Lab Invest. 2004 Nov;84(11):1512-9. doi: 10.1038/labinvest.3700145. Lab Invest. 2004. PMID: 15311211 Free article.

5

Retinoic acid and arsenic for treating acute promyelocytic leukemia.

Zhou GB, Zhao WL, Wang ZY, Chen SJ, Chen Z. Zhou GB, et al. Among authors: zhao wl. PLoS Med. 2005 Jan;2(1):e12. doi: 10.1371/journal.pmed.0020012. PLoS Med. 2005. PMID: 15696202 Free PMC article. Review.

6

NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.

Zhu YM, Zhao WL, Fu JF, Shi JY, Pan Q, Hu J, Gao XD, Chen B, Li JM, Xiong SM, Gu LJ, Tang JY, Liang H, Jiang H, Xue YQ, Shen ZX, Chen Z, Chen SJ. Zhu YM, et al. Among authors: zhao wl. Clin Cancer Res. 2006 May 15;12(10):3043-9. doi: 10.1158/1078-0432.CCR-05-2832. Clin Cancer Res. 2006. PMID: 16707600

7

[BCL-XL expression and mutation in non-Hodgkin's lymphoma].

Liu YH, Leboeuf C, Jin XL, Xiao JC, Janin A, Chen SJ, Zhao WL. Liu YH, et al. Among authors: zhao wl. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Oct;14(5):903-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 17096886 Chinese.

8

Combined effects of histone deacetylase inhibitor and rituximab on non-Hodgkin's B-lymphoma cells apoptosis.

Zhao WL, Wang L, Liu YH, Yan JS, Leboeuf C, Liu YY, Wu WL, Janin A, Chen Z, Chen SJ. Zhao WL, et al. Exp Hematol. 2007 Dec;35(12):1801-11. doi: 10.1016/j.exphem.2007.06.009. Epub 2007 Aug 3. Exp Hematol. 2007. PMID: 17681667 Free article.

9

[Expression of tumor suppressor gene PRDM1 in lung cancers].

Liu YY, Yang SJ, Ma J, Wang L, Liu YH, Chen SJ, Shen ZX, Zhao WL. Liu YY, et al. Among authors: zhao wl. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):434-6. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974277 Chinese.

10

PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor.

Zhao WL, Liu YY, Zhang QL, Wang L, Leboeuf C, Zhang YW, Ma J, Garcia JF, Song YP, Li JM, Shen ZX, Chen Z, Janin A, Chen SJ. Zhao WL, et al. Blood. 2008 Apr 1;111(7):3867-71. doi: 10.1182/blood-2007-08-108654. Epub 2008 Jan 30. Blood. 2008. PMID: 18235046 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters